These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36043734)

  • 1. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
    Massaro L; Raguzzini A; Aiello P; Valencia DV
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.
    Alam MA; Subhan N; Rahman MM; Uddin SJ; Reza HM; Sarker SD
    Adv Nutr; 2014 Jul; 5(4):404-17. PubMed ID: 25022990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
    Yang Y; Trevethan M; Wang S; Zhao L
    J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological activities, Molecular mechanisms, and Clinical application of Naringin in Metabolic syndrome.
    Chen J; Qin X; Chen M; Chen T; Chen Z; He B
    Pharmacol Res; 2024 Apr; 202():107124. PubMed ID: 38428704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of naringenin and naringin on the glucose uptake and AMPK phosphorylation in high glucose treated HepG2 cells.
    Dayarathne LA; Ranaweera SS; Natraj P; Rajan P; Lee YJ; Han CH
    J Vet Sci; 2021 Nov; 22(6):e92. PubMed ID: 34854271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
    Joshi R; Kulkarni YA; Wairkar S
    Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naringenin and naringin in cardiovascular disease prevention: A preclinical review.
    Heidary Moghaddam R; Samimi Z; Moradi SZ; Little PJ; Xu S; Farzaei MH
    Eur J Pharmacol; 2020 Nov; 887():173535. PubMed ID: 32910944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of the adipogenic gene expression by naringenin and naringin in 3T3-L1 adipocytes.
    Dayarathne LA; Ranaweera SS; Natraj P; Rajan P; Lee YJ; Han CH
    J Vet Sci; 2021 Jul; 22(4):e55. PubMed ID: 34313040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis.
    Mulvihill EE; Burke AC; Huff MW
    Annu Rev Nutr; 2016 Jul; 36():275-99. PubMed ID: 27146015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
    Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
    Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrus flavonoids and lipid metabolism.
    Assini JM; Mulvihill EE; Huff MW
    Curr Opin Lipidol; 2013 Feb; 24(1):34-40. PubMed ID: 23254473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (+/-)-naringenin.
    Orallo F; Camiña M; Alvarez E; Basaran H; Lugnier C
    Planta Med; 2005 Feb; 71(2):99-107. PubMed ID: 15729616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nutraceutical potential of Lepidium sativum L. seed flavonoid-rich extract in managing metabolic syndrome components.
    L'hadj I; Azzi R; Lahfa F; Koceir EA; Omari N
    J Food Biochem; 2019 Mar; 43(3):e12725. PubMed ID: 31353542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review on the Pharmacokinetic Properties of Naringin and Its Therapeutic Efficacies in Respiratory Diseases.
    Zeng X; Su W; Liu B; Chai L; Shi R; Yao H
    Mini Rev Med Chem; 2020; 20(4):286-293. PubMed ID: 32134369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of metabolic pharmacokinetics of naringin and naringenin in rabbits.
    Hsiu SL; Huang TY; Hou YC; Chin DH; Chao PD
    Life Sci; 2002 Feb; 70(13):1481-9. PubMed ID: 11895099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Effects of Citrus Flavonoids Neohesperidin, Hesperidin and Its Aglycone, Hesperetin on Bone Health.
    Ortiz AC; Fideles SOM; Reis CHB; Bellini MZ; Pereira ESBM; Pilon JPG; de Marchi MÂ; Detregiachi CRP; Flato UAP; Trazzi BFM; Pagani BT; Ponce JB; Gardizani TP; Veronez FS; Buchaim DV; Buchaim RL
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic Properties of Naringenin: A Citrus Fruit Polyphenol.
    Den Hartogh DJ; Tsiani E
    Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30871083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: Efficacy and molecular mechanisms of action, a comprehensive narrative review.
    Memariani Z; Abbas SQ; Ul Hassan SS; Ahmadi A; Chabra A
    Pharmacol Res; 2021 Sep; 171():105264. PubMed ID: 33166734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-atherogenic effect of citrus flavonoids, naringin and naringenin, associated with hepatic ACAT and aortic VCAM-1 and MCP-1 in high cholesterol-fed rabbits.
    Lee CH; Jeong TS; Choi YK; Hyun BH; Oh GT; Kim EH; Kim JR; Han JI; Bok SH
    Biochem Biophys Res Commun; 2001 Jun; 284(3):681-8. PubMed ID: 11396955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.